Business Wire

HUBHEAD

Share
HubHead Corp. Acquires DataSeer Inc. Assets to Expand its Vertical AI Capabilities

In a strategic move to bolster its vertical AI strategy for asset-intensive industries, HubHead Corp. announced today its acquisition of the assets of DataSeer, Inc. The acquisition adds to HubHead’s portfolio of tools focused on using AI and machine learning to improve asset and maintenance master data and assisting asset-intensive businesses in digitizing data to create digital twins. HubHead’s software improves the effectiveness of our customers’ Enterprise Asset Management (EAM) and CMMS solutions.

As a frontrunner in the application of AI to enhance asset and maintenance master data quality, HubHead is dedicated to collaborating with customers to provide innovative software-as-a-service (SaaS) solutions. AI makes it easier for asset-intensive businesses to ensure their maintenance and operations, and EAM solutions are more efficient, reliable, and prepared for future initiatives.

Greg Dee, CEO of HubHead, emphasized the importance of AI tools to create the asset and maintenance master data foundation needed for operational effectiveness. “At HubHead, we’re driven by the belief that high-quality asset and maintenance data is the cornerstone of EAM effectiveness and is required for effective asset management,” Dee said. “Our strategy focuses on employing AI to enhance the quality and completeness of asset data for our clients. DataSeer is crucial for unlocking the full potential of AI in their industries, enabling critical applications such as digital twins, predictive maintenance, and IoT implementations.”

HubHead has used DataSeer with its NRX AssetHub solution to extract engineering tags from P&IDs to help customers cost-effectively build high-quality EAM/CMMS data. It is used to create digital twins, adopt industry standards like ISO 14224, prepare for operational readiness at new capital projects, enhance asset and maintenance master data prior to migrating or upgrading to new EAM/CMMS solutions, and other applications that create the foundation for operational excellence.

HubHead will offer the DataSeer SaaS solution to engineering firms, system integrators (SIs), EPCs, asset-intensive businesses, and others with a need to scrape P&IDs to extract high-quality actionable asset data.

About HubHead

HubHead Corp. stands at the forefront of vertical AI innovation, providing solutions to maintenance, reliability, and operations professionals across asset-intensive sectors. With a commitment to excellence and a focus on leveraging AI to transform data into actionable insights, HubHead Corp. is dedicated to helping businesses achieve operational efficiency and reliability.

Links:
https://www.nrx.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240418331468/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LabVantage Solutions and The Netherlands Forensic Institute (NFI) Partner to Advance Digital Transformation in Forensic Science4.12.2024 13:30:00 CET | Press release

—New Collaboration Enhances NFI’s IT Infrastructure with Advanced LIMS to Streamline Workflows, Improve Data Integrity, and Optimize Forensic Operations— LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services, including purpose-built LIMS platforms enabling rapid deployment at reduced costs, and The Netherlands Forensic Institute (NFI) today jointly announced a partnership to digitalize forensic laboratory workflows as part of NFI’s IT renewal initiative. A key aspect of this collaboration is the implementation of LabVantage Solutions’ Laboratory Information Management System (LIMS), which is designed to streamline NFI’s forensic operations by replacing fragmented processes and incorporating advanced capabilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204274659/en/ (Graphic: Business Wire) NFI’s IT renewal initiative aims to modernize its infrastructure by replacing outd

DEKA Laser and New York’s Romeo & Juliette: A Global Partnership for Advanced Epilation on Fifth Avenue4.12.2024 13:00:00 CET | Press release

DEKA Laser, global leader in medical laser technologies, proudly announces its new and prestigious partnership with Romeo & Juliette Hair Removal, the renowned center specialized in permanent hair removal located on world-famous Fifth Avenue in New York City. Thanks to this exclusive collaboration, Romeo & Juliette will become another global reference center for DEKA training on laser hair removal, with particular attention to the Again PRO Series line of equipment, and will host the innovative DEKA Epil Academy, an academy dedicated to the training and sharing of advanced hair removal treatment protocols. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241204652458/en/ Located on one of the most elegant and most renowned avenues in the world, Romeo & Juliette Hair Removal is considered true excellence in the aesthetic and medical realm, and is frequented by celebrities, top models and prominent sports personalities. This new

Bluefin Expands Senior Leadership Team to Drive Growth4.12.2024 13:00:00 CET | Press release

New Global Sales and European leadership brings extensive payments industry expertise Bluefin, the recognized integrated payments leader in PCI-validated encryption and tokenization technologies that protect payments and sensitive data, today announced the addition of Andrew Monroe as the company’s new Chief Revenue Officer and Cheng Chieh Chen as Senior Vice President, Europe. As Chief Revenue Officer, Andrew brings extensive experience accelerating revenue growth within the payment industry, most recently as VP Sales and Managing Director, North America at Worldline. With more than 17 years of fintech experience and over 20 years in e-commerce, Andrew will help drive sales growth while the company expands its global footprint. Cheng Chieh Chen will be in charge of accelerating sales and partner growth in Europe. His extensive industry experience includes sales, partnership and commercial management roles at companies such as Shopware, Checkout.com and Klarna. “Bluefin is adding two o

Cirium Enhances Industry-Leading On-Time Performance Advisory Board with Three Esteemed Aviation Leaders4.12.2024 12:12:00 CET | Press release

Cirium, the world’s most trusted source of aviation analytics, has appointed three prominent aviation experts to its Airline and Airport On-Time Performance Advisory Board. The move underscores Cirium’s commitment to maintaining its position as the global gold standard for airline and airport performance analytics. As the first and only company to establish an On-Time Performance Advisory Board, Cirium ensures an unbiased, data-driven view of operational excellence. The latest appointments—Eamonn Brennan, Scott McCartney, and Alex de Gunten—bring over 75 years of combined experience, enhancing the board’s mission to uphold Cirium’s reputation as the industry benchmark. Jeremy Bowen, Cirium CEO, said “Adding Eamonn, Scott, and Alex to our Advisory Board is a confirmation of our unwavering commitment to operational reliability and excellence. Their unique perspectives, spanning safety, operations, performance, journalism, and global airline strategy, will amplify our ability to provide i

Delta-Fly Pharma Inc.: Update for Development Status of DFP-177294.12.2024 12:00:00 CET | Press release

We are excited to share our latest development status. We are pleased to announce that as a result of consultation with the PMDA on December 3rd, 2024, the Phase II/III clinical trial of DFP-17729 in combination with TS-1 versus TS-1 alone in patients with pancreatic cancer after third-line treatment was approved. In a Phase I/II study of DFP-17729 in combination with TS-1 in patients with end-stage pancreatic cancer, no significant difference was observed against the control treatment (TS-1 or gemcitabine), but stratified analysis showed that when patients in the third-line or later treatment were treated for more than 6 weeks, DFP-17729 in combination with TS-1 showed a predominant median overall survival (mOS) prolongation (9.0 months vs. 6.1 months) and a significant correlation was also observed between urinary alkalinization and mOS in pancreatic cancer patients treated with DFP-17729, as key proof of concept. We had presented these results at the ESMO Gastrointestinal Cancers Co

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye